Glucagon‐like peptide‐1 (GLP-1) receptor agonists have emerged as promising therapeutic options for addressing type‐2 diabetes, obesity, and related conditions. However,...
Continue Reading
Introduction: Diabetes is a chronic, metabolic disease resulting from defects in insulin secretion and varying degrees of insulin resistance. Early...
Continue Reading Salt-inducible kinases (SIKs) have recently emerged as key regulators of oncogenesis, inflammation, and immune responses, making these enzymes an important...
Continue Reading Animal studies may provide a close approximation to humans when addressing the key challenge of clinical translatability. In the preclinical...
Continue Reading
In this case study, we demonstrate clinical relevance of the HFD+CCL4 (high-fat diet and carbon tetrachloride) NASH animal model. Improvement...
Continue Reading As part of our dedication to providing an #openaccess platform, so our entire ecosystem can come together to share #science...
Continue Reading WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to...
Continue Reading The hepatic fibrosis has been the most challenging aspect in the animal models for nonalcoholic steatohepatitis (NASH). Although it could...
Continue Reading
